The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
NAFLD as a driver of chronic kidney disease
Abstract
Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) are worldwide public health problems, affecting up to 25-30% (NAFLD), and up to 10-15% (CKD) of the general population. Recently, it has also been established that there is a strong association between NAFLD and CKD, regardless of the presence of potential confounding diseases such as obesity, hypertension and type 2 diabetes. Since NAFLD and CKD are both common diseases that often occur alongside other metabolic conditions, such as type 2 diabetes or metabolic syndrome, elucidating the relative impact of NAFLD on the risk of incident CKD presents a substantial challenge for investigators working in this research field. A growing body of epidemiological evidence suggests that NAFLD is an independent risk factor for CKD and recent evidence also suggests that associated factors such as metabolic syndrome, dysbiosis, unhealthy diets, platelet activation and processes associated with ageing could also contribute mechanisms linking NAFLD and CKD. This narrative review provides an overview of the literature on: a) the evidence for an association and causal link between NAFLD and CKD and b) the underlying mechanisms by which NAFLD (and factors strongly linked with NAFLD) may increase the risk of developing CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, there is uncertainty as to whether there is a direct causal link between MASLD and CKD as both diseases share common risk factors. 227”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [227]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, R. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,320
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,162
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708
Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
Couser, W. G., Remuzzi, G., Mendis, S., & Tonelli, M. A. (2011) · Kidney International · doi:10.1038/ki.2011.368 · Cited by 1,553
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,429
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,228
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00600.x · Cited by 1,179
Evolving importance of kidney disease: from subspecialty to global health burden
Eckardt, K.-U., Coresh, J., Devuyst, O., Johnson, R. J., Köttgen, A., Levey, A. S., & Levin, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60439-0 · Cited by 1,159
Krötz, F., Sohn, H., & Pohl, U. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000145574.90840.7d · Cited by 1,030
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 753
Intestinal microbiota in patients with nonalcoholic fatty liver disease
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749
Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R. W., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 741
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress
Lanaspa, M. A., Sánchez‐Lozada, L. G., Choi, Y.-J., Cicerchi, C., Kanbay, M., Roncal-Jiménez, C. A., Ishimoto, T., Li, N., Marek, G. W., Duranay, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399899 · Cited by 728
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2016) · Diabetologia · doi:10.1007/s00125-016-3902-y · Cited by 695
Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y. C., Li, J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep08096 · Cited by 660
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Mantovani, A., Byrne, C. D., Bonora, E., & Targher, G. (2018) · Diabetes Care · doi:10.2337/dc17-1902 · Cited by 634
CKD Prevalence Varies across the European General Population
Brück, K., Stel, V. S., Gambaro, G., Hallan, S. I., Völzke, H., Ärnlöv, J., Kastarinen, M. J., Guessous, I., Vinhas, J., Stengel, B., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050542 · Cited by 609
Fructose metabolism and metabolic disease
Hannou, S. A., Haslam, D. E., McKeown, N. M., & Herman, M. A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96702 · Cited by 561
Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis
Thomas, G., Sehgal, A. R., Kashyap, S. R., Srinivas, T. R., Kirwan, J. P., & Navaneethan, S. D. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02180311 · Cited by 553
Oxidative stress, anti‐oxidant therapies and chronic kidney disease
Small, D. M., Coombes, J. S., Bennett, N. J., Johnson, D. W., & Gobe, G. C. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01572.x · Cited by 529
Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
Johnson, R. J., Perez-Pozo, S. E., Sautin, Y. Y., Manitius, J., Sánchez‐Lozada, L. G., Feig, D. I., Shafiu, M., Segal, M. S., Glassock, R. J., Shimada, M., et al. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0033 · Cited by 509
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez‐Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 452
The epidemiology of non‐alcoholic fatty liver disease
Bellentani, S. (2017) · Liver international (Print) · doi:10.1111/liv.13299 · Cited by 416
Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD
Dounousi, E. C., Papavasiliou, E. C., Makedou, A., Ioannou, K. I., Katopodis, K. P., Tselepis, A. D., Siamopoulos, K. C., & Tsakiris, D. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.015 · Cited by 412
Younossi, Z. M., Marchesini, G., Cortez‐Pinto, H., & Petta, S. (2018) · Transplantation · doi:10.1097/tp.0000000000002484 · Cited by 405
Malehmir, M., Pfister, D., Gallage, S., Szydlowska, M., Inverso, D., Kotsiliti, E., Leone, V., Peiseler, M., Surewaard, B. G. J., Rath, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0379-5 · Cited by 398 · cited 5×
“NASH and subsequent development of hepatocellular carcinoma in a murine hIL4r-alpha-/GP1balpha transgenic mouse model of NASH.(126) In addition, intra-vital microscopy also showed that”
BackgroundInfluentialDuni, Α., Liakopoulos, V., Roumeliotis, S. K., Peschos, D., & Dounousi, E. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153711 · Cited by 393
Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Lippi, G., Day, C. P., & Muggeo, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0897-4 · Cited by 384
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
Pirazzi, C., Valenti, L. V. C., Motta, B. M., Pingitore, P., Hedfalk, K., Mancina, R. M., Burza, M. A., Indiveri, C., Ferro, Y., Montalcini, T., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu121 · Cited by 363
Oxidative stress in uremia: Nature, mechanisms, and potential consequences
Vaziri, N. D. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.06.026 · Cited by 357
Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease
Ix, J. H., & Sharma, K. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009080820 · Cited by 355
Mantovani, A., Zaza, G., Byrne, C. D., Lonardo, A., Zoppini, G., Bonora, E., & Targher, G. (2017) · Metabolism · doi:10.1016/j.metabol.2017.11.003 · Cited by 348
Cellular senescence: at the nexus between ageing and diabetes
Palmer, A. K., Gustafson, B., Kirkland, J. L., & Smith, U. (2019) · Diabetologia · doi:10.1007/s00125-019-4934-x · Cited by 337
Fermentation in the human large intestine: evidence and implications for health
Cummings, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92478-9 · Cited by 336
Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis
Alexopoulos, N. A., Katritsis, D. G., & Raggi, P. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.023 · Cited by 333
Hallmarks of Aging in the Liver
Hunt, N. J., Kang, S. W., Lockwood, G. P., Couteur, D. G. L., & Cogger, V. C. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.07.021 · Cited by 320
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
Targher, G., & Byrne, C. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.16 · Cited by 315
Ashraf, N. U., & Sheikh, T. A. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1078461 · Cited by 312
Evenepoel, P., Poesen, R., & Meijers, B. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3527-x · Cited by 305
Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease
Siragy, H. M., & Carey, R. M. (2010) · American Journal of Nephrology · doi:10.1159/000313363 · Cited by 304
The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_9 · Cited by 299
Involvement of free radicals and oxidative stress in NAFLD/NASH
Sumida, Y., Niki, E., Naito, Y., & Yoshikawa, T. (2013) · Free Radical Research · doi:10.3109/10715762.2013.837577 · Cited by 280
Lanaspa, M. A., Ishimoto, T., Li, N., Cicerchi, C., Orlicky, D. J., Ruzycki, P. A., Rivard, C. J., Inaba, S., Roncal-Jiménez, C. A., Bales, E. S., et al. (2013) · Nature Communications · doi:10.1038/ncomms3434 · Cited by 259
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
Anstee, Q. M., Seth, D., & Day, C. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.037 · Cited by 254
Non-Alcoholic Fatty Liver Disease
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_19 · Cited by 253
Adipose tissue inflammation in obesity: A metabolic or immune response?
Stolarczyk, E. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.08.006 · Cited by 247
Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review
Levey, A. S., & Inker, L. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.729 · Cited by 244
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Zoppini, G., & Chonchol, M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05050610 · Cited by 237
Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M., Bertolini, L., Rodella, S., Zenari, L., Lippi, G., Franchini, M., Zoppini, G., & Muggeo, M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101155 · Cited by 236
CKD and Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M. B., & Byrne, C. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.019 · Cited by 221
Ryu, S., Chang, Y., Kim, D., Kim, W. S., & Suh, B.-S. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.078980 · Cited by 218
Rosso, C., Kazankov, K., Younes, R., Esmaili, S., Marietti, M., Sacco, M., Carli, F., Gaggini, M., Salomone, F., Møller, H. J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.031 · Cited by 217
Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease
Wieland, A. C., Frank, D. N., Harnke, B., & Bambha, K. M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13376 · Cited by 211
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease
Sabatino, A., Regolisti, G., Cosola, C., Gesualdo, L., & Fiaccadori, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0841-z · Cited by 202
NAFLD and Chronic Kidney Disease
Marcuccilli, M. E., & Chonchol, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040562 · Cited by 201
Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
Lanaspa, M. A., Cicerchi, C., García, G., Li, N., Roncal-Jiménez, C. A., Rivard, C. J., Hunter, B., Andrés-Hernando, A., Ishimoto, T., Sánchez‐Lozada, L. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048801 · Cited by 192
Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease
Kendrick, J., & Chonchol, M. B. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0954 · Cited by 187
Role of Klotho in Aging, Phosphate Metabolism, and CKD
John, G. B., Cheng, C.-Y., & Kuro‐o, M. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.12.027 · Cited by 185
Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease
Byrne, C. D., & Targher, G. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303034 · Cited by 179
The impact of gut microbiota on kidney function and pathogenesis
Mahmoodpoor, F., Saadat, Y. R., Barzegari, A., Ardalan, M., & Vahed, S. Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.066 · Cited by 172
Intestinal Microbiota and Nonalcoholic Steatohepatitis
Brandl, K., & Schnabl, B. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000349 · Cited by 169
Emerging risk factors and markers of chronic kidney disease progression
Kronenberg, F. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.173 · Cited by 166
Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities
Musso, G., Cassader, M., Cohney, S. J., Michieli, F. D., Pinach, S., Saba, F., & Gambino, R. (2016) · Diabetes Care · doi:10.2337/dc15-1182 · Cited by 165
Yang, K., Du, C., Wang, X., Li, F., Xu, Y., Wang, S., Chen, S., Chen, F., Shen, M., Chen, M., et al. (2017) · Blood · doi:10.1182/blood-2016-10-744060 · Cited by 165
Metabolic syndrome and chronic kidney disease: Current status and future directions
Prasad, G. V. R. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i4.210 · Cited by 164
Chang, Y., Ryu, S., Sung, E., Woo, H., Oh, E., Cha, K., Jung, E., & Kim, W. S. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.022 · Cited by 164
Sinn, D. H., Kang, D., Jang, H. R., Gu, S., Cho, S. J., Paik, S. W., Ryu, S., Chang, Y., Lazo, M., Güallar, E., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.024 · Cited by 164
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
Yasui, K., Sumida, Y., Mori, Y., Mitsuyoshi, H., Minami, M., Itoh, Y., Kanemasa, K., Matsubara, H., Okanoue, T., & Yoshikawa, T. (2010) · Metabolism · doi:10.1016/j.metabol.2010.07.022 · Cited by 161
Mosca, A., Nobili, V., De Vito, R., Crudele, A., Scorletti, E., Villani, A., Alisi, A., & Byrne, C. D. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.025 · Cited by 161
Targher, G., Mantovani, A., Pichiri, I., Mingolla, L., Cavalieri, V., Mantovani, W., Pancheri, S., Trombetta, M., Zoppini, G., Chonchol, M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2704 · Cited by 159
Targher, G., Bertolini, L., Chonchol, M., Rodella, S., Zoppini, G., Lippi, G., Zenari, L., & Bonora, E. (2010) · Diabetologia · doi:10.1007/s00125-010-1720-1 · Cited by 158
Kidney Pericytes: Roles in Regeneration and Fibrosis
Kramann, R., & Humphreys, B. D. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.06.004 · Cited by 158
Targher, G., Chonchol, M., Miele, L., Zoppini, G., Pichiri, I., & Muggeo, M. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1222606 · Cited by 144
Diagnosis and management of non-alcoholic fatty liver disease
Jennison, E., Patel, J., Scorletti, E., & Byrne, C. D. (2019) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2018-136316 · Cited by 142
Passmore, I. J., Letertre, M. P. M., Preston, M. D., Bianconi, I., Harrison, M. A., Nasher, F., Kaur, H., Hong, H. A., Baines, S. D., Cutting, S. M., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007191 · Cited by 141
Wild, S. H., Walker, J. J., Morling, J. R., McAllister, D., Colhoun, H. M., Farran, B., McGurnaghan, S. J., McCrimmon, R. J., Read, S. H., Sattar, N. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1590 · Cited by 138
The Biological Role of Klotho Protein in the Development of Cardiovascular Diseases
Olejnik, A., Franczak, A., Krzywonos‐Zawadzka, A., Kałużna‐Oleksy, M., & Bil‐Lula, I. (2018) · BioMed Research International · doi:10.1155/2018/5171945 · Cited by 136
Blanc, J. L., & Lordkipanidzé, M. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00109 · Cited by 133
Sánchez‐Lozada, L. G., Andrés-Hernando, A., García‐Arroyo, F. E., Cicerchi, C., Li, N., Kuwabara, M., Roncal-Jiménez, C. A., Johnson, R. J., & Lanaspa, M. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006158 · Cited by 128
Duni, Α., Liakopoulos, V., Rapsomanikis, K.-P., & Dounousi, E. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9036450 · Cited by 127
Akbari, A., Clase, C. M., Acott, P., Battistella, M., Bello, A. K., Feltmate, P., Grill, A. K., Karsanji, M., Komenda, P. V. J., Madore, F., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.10.013 · Cited by 125
Clinical and research markers of oxidative stress in chronic kidney disease
Tucker, P. S., Dalbo, V. J., Han, T., & Kingsley, M. (2013) · Biomarkers · doi:10.3109/1354750x.2012.749302 · Cited by 124
Gremmel, T., Müller, M., Steiner, S., Seidinger, D., Koppensteiner, R., Kopp, C., & Panzer, S. (2013) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gft103 · Cited by 123
Pericytes in the renal vasculature: roles in health and disease
Shaw, I., Rider, S., Mullins, J. J., Hughes, J., & Péault, B. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0032-4 · Cited by 118
Effects of VLDL and remnant particles on platelets.
Olufadi, R., & Byrne, C. D. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093221 · Cited by 111
Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
Byrne, C. D., Patel, J., Scorletti, E., & Targher, G. (2018) · BMJ · doi:10.1136/bmj.k2734 · Cited by 110
Jang, H. R., Kang, D., Sinn, D. H., Gu, S., Cho, S. J., Lee, J. E., Huh, W., Paik, S. W., Ryu, S., Chang, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23014-0 · Cited by 110
The role of the anti-ageing protein Klotho in vascular physiology and pathophysiology
Mencke, R., & Hillebrands, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.001 · Cited by 104
Yilmaz, Y. N., Alahdab, Y. Ö., Yönal, O., Kurt, R., Kedrah, A. E., Çelikel, Ç., Ozdogan, O. C., Duman, D., İmeryüz, N., Avşar, E., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.012 · Cited by 102
Holt, H., Wild, S. H., Wood, P. J., Zhang, J.-L., Darekar, A., Dewbury, K. C., Poole, R., Holt, R. I. G., Phillips, D. I., & Byrne, C. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0070-x · Cited by 100
Platelets as Key Factors in Hepatocellular Carcinoma
Pavlovic, N., Rani, B., Gerwins, P., & Heindryckx, F. (2019) · Cancers · doi:10.3390/cancers11071022 · Cited by 97
Byrne, C. D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03732.x · Cited by 96
NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis
Eduardo Fuentes, Q., Gibbins, J. M., Holbrook, L., & Palomo, I. F. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.03.001 · Cited by 93
Hwang, S. T., Cho, Y. K., Yun, J. W., Park, J. H., Kim, H., Park, D. I., Sohn, C. I., Jeon, W. K., Kim, B., Rhee, E., et al. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.01979.x · Cited by 91
Sirota, J. C., Mcfann, K., Targher, G., Chonchol, M., & Jalal, D. (2012) · American Journal of Nephrology · doi:10.1159/000343885 · Cited by 90
Sun, D., Zheng, K. I., Xu, G., Ma, H., Zhang, H., Pan, X., Zhu, P., Wang, X., Targher, G., Byrne, C. D., et al. (2019) · Liver International · doi:10.1111/liv.14251 · Cited by 86
Oniki, K., Saruwatari, J., Izuka, T., Kajiwara, A., Morita, K., Sakata, M., Otake, K., Ogata, Y., & Nakagawa, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132640 · Cited by 76
Önnerhag, K., Hartman, H., Nilsson, P. M., & Lindgren, S. C. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1583366 · Cited by 76
Park, H., Dawwas, G. K., Liu, X., & Nguyen, M. H. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12964 · Cited by 75
Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review
Chung, S.-Y., Barnes, J. L., & Astroth, K. S. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz028 · Cited by 72
Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease
Machado, M. V., Gonçalves, S., Carepa, F., Coutinho, J., Costa, A., & Cortez‐Pinto, H. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02623.x · Cited by 71
Paik, J. M., Golabi, P., Younoszai, Z., Mishra, A., Trimble, G., & Younossi, Z. M. (2018) · Liver International · doi:10.1111/liv.13992 · Cited by 69
Briskey, D. R., Tucker, P. S., Johnson, D. W., & Coombes, J. S. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-016-1255-y · Cited by 68
Gómez, E. V., Bertot, L. C., Friedman, S. L., Gra‐Oramas, B., Gonzalez‐Fabian, L., Villa-Jiménez, O. M., del Vallín, S. L., Diago, M., Adams, L. A., Romero‐Gómez, M., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13860 · Cited by 67
Huh, J. H., Kim, J., Choi, E. H., Kim, J. S., Chang, Y., & Sung, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180951 · Cited by 67
Targher, G., Mantovani, A., Alisi, A., Mosca, A., Panera, N., Byrne, C. D., & Nobili, V. (2019) · Hepatology · doi:10.1002/hep.30625 · Cited by 65
Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases
Kim, H., Joo, E., Cheong, H. S., Kim, Y., Kim, H., Shin, H. C., Chang, Y., & Ryu, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081089 · Cited by 61
Arase, Y., Suzuki, F., Kobayashi, M., Suzuki, Y., Kawamura, Y., Matsumoto, N., Akuta, N., Kobayashi, M., Sezaki, H., Saito, S., et al. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5043 · Cited by 59
A Novel Role for CD36 in VLDL-Enhanced Platelet Activation
Englyst, N. A., Taube, J. M., Aitman, T. J., Baglin, T. P., & Byrne, C. D. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1248 · Cited by 59
Byrne, C. D., & Targher, G. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1334866 · Cited by 58
What’s new in NAFLD pathogenesis, biomarkers and treatment?
Byrne, C. D., & Targher, G. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0239-2 · Cited by 58
Park, C. W., Tsai, N., & Wong, L. L. (2011) · Clinical Transplantation · doi:10.1111/j.1399-0012.2011.01497.x · Cited by 57
Musso, G., Cassader, M., & Gambino, R. (2014) · Hepatology · doi:10.1002/hep.27643 · Cited by 56
The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity
Pacifico, L., Bonci, E., Andreoli, G., Martino, M. D., Gallozzi, A., Luca, E. D., & Chiesa, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081218 · Cited by 56
In Vitro Modeling of Bile Acid Processing by the Human Fecal Microbiota
Martin, G., Kolida, S., Marchesi, J. R., Want, E. J., Sidaway, J. E., & Swann, J. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01153 · Cited by 55
Marzuillo, P., Sessa, A. D., Guarino, S., Capalbo, D., Umano, G. R., Pedullà, M., Manna, A. L., Cirillo, G., & del Giudice, E. M. (2019) · Pediatric Obesity · doi:10.1111/ijpo.12539 · Cited by 48
Role of Inflammasome in Chronic Kidney Disease
Li, L., Tang, W., & Yi, F. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_19 · Cited by 44
Mantovani, A., Zusi, C., Sani, E., Colecchia, A., Lippi, G., Zaza, G., Valenti, L. V. C., Byrne, C. D., Maffeis, C., Bonora, E., et al. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.011 · Cited by 43
Costanzo, A. D., Pacifico, L., D’Erasmo, L., Polito, L., Martino, M. D., Perla, F. M., Iezzi, L., Chiesa, C., & Arca, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184444 · Cited by 41
Scorletti, E., & Byrne, C. D. (2016) · Digestive Diseases · doi:10.1159/000447276 · Cited by 40
Halilbasic, E., Fuchs, C. D., Traussnigg, S., & Trauner, M. (2016) · Digestive Diseases · doi:10.1159/000445268 · Cited by 39
Musso, G., Michieli, F. D., Bongiovanni, D., Parente, R., Framarin, L., Leone, N., Berrutti, M., Gambino, R., Cassader, M., Cohney, S. J., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.002 · Cited by 38
Nampoothiri, R. V., Duseja, A. K., Rathi, M., Agrawal, S., Sachdeva, N. K., Mehta, M., Dhaliwal, H. S., Dhiman, R. K., & Chawla, Y. K. (2017) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2017.12.005 · Cited by 36
Önnerhag, K., Dreja, K., Nilsson, P. M., & Lindgren, S. C. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.02.004 · Cited by 35
Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older
Ahn, A.-L., Choi, J., Kim, M. K., Kim, S.-A., Oh, E.-J., Kweon, H.-J., & Cho, D.-Y. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.3.199 · Cited by 34
Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study
Kunutsor, S. K., & Laukkanen, J. A. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.014 · Cited by 34
Pan, L., Zhang, H., Huang, Z., Sun, Q., Chen, Z., Li, Z., Yang, S., Li, X.-Y., & Li, X. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.003 · Cited by 33
Wilechansky, R. M., Pedley, A., Massaro, J. M., Hoffmann, U., Benjamin, E. J., & Long, M. T. (2019) · Liver International · doi:10.1111/liv.14125 · Cited by 32
The correlation between fatty liver disease and chronic kidney disease
Chen, P., Kao, W., Cheng, Y.-L., Wang, Y., Hou, M., Wu, J., & Su, C. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.02.010 · Cited by 29
Immunodetection of aldose reductase in normal and diseased human liver.
Brown, K. E., Broadhurst, K. A., Mathahs, M. M., Kladney, R. D., Fimmel, C. J., Sk, S., & Brunt, E. M. (2005) · PubMed · doi:10.14670/hh-20.429 · Cited by 28
Shen, Z., Xing, J., Wang, Q., Faheem, A., Ji, X., Li, J., Bian, W., Jiang, Z., Li, X., Xue, F., et al. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1429-2 · Cited by 28
Luo, K., Bian, J., Wang, Q., Wang, J., Chen, F., Li, H., & Jin, D. (2019) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2019.18343 · Cited by 16
Cited by
Sorted by citations
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Targher, G., Byrne, C. D., & Tilg, H. (2020) · Gut · doi:10.1136/gutjnl-2020-320622 · Cited by 879
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627
Metadata
- Authors
- Byrne, C. D., & Targher, G.
- Affiliations
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Verona (IT)
- Corresponding author
- Byrne, Christopher D.
- Targher, Giovanni
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 72
- Issue
- 4
- Pages
- 785-801
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3006576880
- Cited by
- 449
- References
- 144
- Citations by year
- 2026: 45 · 2025: 72 · 2024: 76 · 2023: 85 · 2022: 79 · 2021: 57 · 2020: 34
- FWCI
- 9.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Funders
- NIHR Bristol Biomedical Research Centre (IS-BRC-20004)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, chronic kidney disease, CKD risk factors, metabolic syndrome, dysbiosis, platelet activation, aging, type 2 diabetes, obesity, hypertension, unhealthy diet, pathophysiological mechanisms
- MeSH terms
- Adolescent, Adult, Aging, Child, Diabetes Mellitus, Type 2, Diet, Female, Humans, Male, Middle Aged, Obesity, Risk Factors, Platelet Activation, Comorbidity, Prevalence, Metabolic Syndrome, Renal Insufficiency, Chronic, Young Adult, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
